Elisabet Selga Coma
Coordinator of the Determinants of Arrhythmogenesis Research Line
Email: elisabet.selga@umedicina.cat
ORCID: 0000-0002-4290-8370
Scientific Profile: URECERCA
Elisabet Selga is an associate professor at the Faculty of Medicine of the Universitat de Vic – Universitat Central de Catalunya.
Dr. Selga is a biologist (2004, UdG) and developed her Ph.D. on the identification of genomic nodes involved in the response to chemotherapeutic treatment with methotrexate (2009, UB). Then she moved to IDIBGI, and under a postdoctoral Sara Borrell fellowship (2012 – 2014), Dr. Selga investigated the pathophysiological effects of genetic variants in cardiac ion channels identified in patients with inherited cardiac disorders and in cases of unexplained sudden death. Her international research stay (2013 – 2014) at the prestigious MRC Centre for Regenerative Medicine in Edinburgh allowed her to implement patient-specific induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) as a cellular model to assess pathophysiological mechanisms and pharmacological responses in patients with Brugada syndrome.
In 2018 she moved to UVic-UCC as professor, and joined IRIS-CC. Since then, her research interests are I) to uncover the cardiac and neurological risk factors that lead to sudden cardiac death, and II) to quantify the impact of a holistic cardiac rehabilitation program on clinical and biochemical biomarkers, on the microbiome and on the mechanisms of atrial inflammation in patients diagnosed with atrial fibrillation and overweight/obesity.
My last happenings:
Bringing Science Closer to the Classroom for a Second Consecutive Year during European Researchers’ Night 2026
As part of European Researchers' Night 2026, PhD candidate Clara Masó once again visited Els Castanyers School in Viladrau to bring science closer to young students. For the second consecutive year, pupils from 3rd, 4th and 5th grade took part in interactive workshops designed to introduce them to scientific research, health, hygiene, microorganisms and the scientific method through hands-on activities and discussion. During the first visit, Clara introduced pupils to several key scientific concepts, including the scientific method, the contributions of women in science, how wounds heal and why some wounds fail to heal, advanced wound therapies used in [...]
Comprehensive proteomic profiling of platelet-rich plasma from elderly individuals: insights for autologous therapeutic applications
Authors: Anna Buisán-Farré, Montserrat Serra-Mas, Elisabet Sarri, Verónica Salgado-Pacheco, Gianluca Arauz-Garofalo, Antonia Odena-Caballol, Marta Vilaseca, Marina Gay, Marta Ferrer-Solà, Clara Masó-Albareda, Marta Casals-Zorita, Marta Otero-Viñas Clinical Proteomics. 2026 DOI: 10.1186/s12014-026-09630-3 Funding: Instituto de Salud Carlos III (PI19/01379 and PI24/00211), the European Union, the PECT Osona Transformació Social project (001-P-000382), the INVESTIGO programme (2022 INV-1 00037), and a doctoral fellowship from the University of Vic-Central University of Catalonia. Proteomics analyses were performed at the IRB Barcelona Mass Spectrometry and Proteomics Core Facility (IU16-015983). Read more Abstract Background Autologous platelet-rich plasma (PRP) is commonly used to enhance tissue repair. [...]
TR2Lab was present at ETRS 2026 Annual Meeting
Dr.Elisabet Sarri and PhD candidate Natalia Palacio, members of TR2Lab, participated in the ETRS 2026 Annual Meeting, "Research, Repair, Regenerate", held in Rouen, France, from 2 to 4 September 2026. Organized by the European Tissue Repair Society (ETRS), the meeting is recognized as one of the leading international forums for researchers and clinicians working in tissue repair, wound healing and regenerative medicine. The conference brought together experts from across Europe and beyond to discuss emerging strategies for improving wound healing, with scientific sessions covering topics such as inflammation and tissue repair, biomaterials and bioengineering, wound microbiology and biofilms, stem cells, [...]
